Otros efectos secundarios pueden incluir mareos, aumento de la frecuencia cardaca, infecciones, dolores de cabeza e indigestin
Improved Liver Function: They can improve markers associated with non-alcoholic fatty liver disease closely tied to obesity
Clinical Trial Results Comparison Three landmark Phase 3 trials provide the comparison data
Gala GLP-1 connects patients with licensed healthcare providers who independently evaluate eligibility for treatment
Here are the drugs they reviewed: Other conditions now being evaluated for GLP-1 effectiveness include: Parkinsons Disease Alzheimers dementia Alcohol use disorder These drugs are also being evaluated for obsessive-compulsive disorder, opioid use disorder, gambling, and other mental health diagnoses, although these are not mentioned in this review
CLICK HERE TO DOWNLOAD THE FOX NEWS APP "And then I realized the very first time I took the GLP-1 that oh, theyre not even thinking about it